This webinar provided an overview of animal infection models commonly used for studies of antibiotics against gram-negative bacteria. The webinar was driven by the COMBINE objective to harmonse and standardise […]
December 3, 2020, 3.30PM-4.30PM CET Peter Warn is an experienced antimicrobial discovery scientist and consultant with a long and successful record of working in the anti-infective discovery industry. His expertise […]
The webinar covered processes for working with aggregated clinical data in the COMBINE consortium and AMR Accelerator. Firstly, the team outlined a set of procedures established for assessing the ethical […]
This workshop provided an open discussion forum to identify, propose and prioritise specific challenges, success and risk factors in the development of vaccines against nosocomial AMR pathogens. Participants included experts […]
The COMBINE project is part of the IMI AMR Accelerator. One of the scientific aims of COMBINE is to improve and standardize the pneumonia animal model used in AMR research […]
This webinar provided a unique opportunity for the antibiotic community. The Innovative Medicines Initiative's GNA NOW Consortium was looking for a novel antibiotic compound to progress to a clinical candidate […]
This webinar will cover the use of knowledge management tools in the IMI AMR Accelerator and how these can be used to both enhance data analysis workflows and also […]
GNA NOW Open Call webinar II This webinar provided a unique opportunity for the antibiotic community. The Innovative Medicines Initiative’s GNA NOW Consortium was looking for a novel antibiotic compound […]
About twenty people attended this webinar which focused on TB research within the IMI AMR Accelerator. During the first part of this TB research focused webinar, Martin Boeree (UNITE4TB and […]
The 2nd Annual meeting for the Cross-IMI AMR Accelerator community was held online on 28 September 2021 and brought together >160 members of the 8 AMR Accelerator projects. After an […]